Masimo | MASI - Gross Profit On Sales


Masimo reported $247.3M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Accuray USD 41.89M 7.42M Dec/2024
Align Technology USD 683.59M 44.39M Dec/2025
AngioDynamics USD 44.78M 2.93M Sep/2025
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 105.34M 4M Dec/2025
Avanos Medical USD 86M 0 Dec/2025
Baxter International USD 577M 373M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Boston Scientific USD 3.61B 64M Mar/2026
Dexcom USD 792.7M 61.3M Dec/2025
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
General Electric Aerospace USD 4.24B 439M Mar/2026
Globus Medical USD 535.95M 49.28M Dec/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 568.6M 58.5M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
Intuitive Surgical USD 1.83B 73.8M Mar/2026
Masimo USD 247.3M 16.7M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Orthofix International USD 153.28M 4.76M Dec/2025
Owens Minor USD 272.05M 20.92M Dec/2025
ResMed USD 878.72M 57.9M Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025